4.4 Article

Proposed Recommendations for the Management of Depression in Adults with Epilepsy: An Expert Consensus

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

ILAE clinical practice recommendations for the medical treatment of depression in adults with epilepsy

Marco Mula et al.

Summary: This document provides evidence-based recommendations for the medical treatment of depression in adults with epilepsy, covering drug treatments, psychological interventions, and other treatment strategies. SSRIs are recommended as first-line medications for moderate to severe depressive episodes, but switching to venlafaxine is legitimate for patients who do not respond to first-line treatment. Treatment should be maintained for at least 6 months following remission from a first depressive episode, with longer durations for patients with a history of previous episodes or severe depression.

EPILEPSIA (2022)

Article Clinical Neurology

Web-based decision support system for patient-tailored selection of antiseizure medication in adolescents and adults: An external validation study

Levente Hadady et al.

Summary: The study validated that the use of the algorithm recommending ASMs based on individual characteristics is associated with better outcomes compared to using less desirable ASMs, including higher retention rates, higher seizure freedom rates, and fewer discontinuations due to adverse effects. The freely available decision support system proved to be beneficial for healthcare professionals in prescribing medication for individuals with epilepsy.

EUROPEAN JOURNAL OF NEUROLOGY (2022)

Article Clinical Neurology

Comparative effects of 15 antidepressants on the risk of withdrawal syndrome: A real-world study using the WHO pharmacovigilance database

Jean-Baptiste Quilichini et al.

Summary: This study found that the use of short half-life antidepressants is associated with an increased risk of reporting withdrawal syndrome compared to long half-life antidepressants in patients. Especially for patients aged 18-44, women, and those treated with Paroxetine, Desvenlafaxine, Venlafaxine, and Duloxetine. These findings provide guidance for clinical practice.

JOURNAL OF AFFECTIVE DISORDERS (2022)

Review Clinical Neurology

Suicidality and antiepileptic drugs in people with epilepsy: an update

Marco Mula

Summary: This review discusses the role of antiseizure medications (ASMs) in the context of suicide in epilepsy. The available literature does not provide clear support for a causal relationship between ASMs and suicide. Instead, studies emphasize the complex relationship between suicide and epilepsy, highlighting the bidirectional relationship and multifactorial origin.

EXPERT REVIEW OF NEUROTHERAPEUTICS (2022)

Review Medicine, General & Internal

Antiseizure Medications for Adults With Epilepsy A Review

Andres M. Kanner et al.

Summary: Epilepsy is a common condition affecting approximately 65 million people worldwide. Proper treatment is crucial, as epilepsy can lead to bodily injuries and increased mortality rates. The choice of medication should be based on the type of epilepsy, individual patient factors, and potential drug interactions.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

Review Behavioral Sciences

Suicidality in Patients With Epilepsy: Why Should Neurologists Care?

Andres M. Kanner

Summary: Suicidality is relatively common in patients with epilepsy, with multiple risk factors including socio-demographic, genetic, and psychiatric comorbidities. Mood, anxiety, and psychotic disorders are common risk factors for suicidality in epilepsy patients. Screening tools can easily identify suicidal ideation in outpatient epilepsy clinics.

FRONTIERS IN INTEGRATIVE NEUROSCIENCE (2022)

Article Behavioral Sciences

Initiating antiepilepsy treatment: An update of expert consensus in Spain

Vicente Villanueva et al.

Summary: This study used the Delphi method to update expert consensus on the initiation of epilepsy treatment, focusing on decision-making factors for when to start treatment, choice of initial monotherapy based on epilepsy type and patient demographics, and selection of initial monotherapy based on comorbidities. The study found general agreement to initiate treatment after certain seizure types and highlighted specific recommendations for different patient groups and comorbidities.

EPILEPSY & BEHAVIOR (2021)

Article Behavioral Sciences

Does a psychiatric history play a role in the development of psychiatric adverse events to perampanel. .. and to placebo?

Andres M. Kanner et al.

Summary: Patients with a psychiatric history are at a higher risk of developing psychiatric treatment-emergent adverse events (PTEAEs) when randomized to perampanel (PER), especially at doses above 8mg/day. Close monitoring and evaluation are recommended for these patients during treatment.

EPILEPSY & BEHAVIOR (2021)

Article Behavioral Sciences

How frequently is anxiety and depression identified and treated in hospital and community samples of adults with epilepsy?

Amelia J. Scott et al.

Summary: This study aimed to understand the rates of confirmed diagnosis and treatment of depression and anxiety in people with epilepsy. Findings showed that in the hospital sample, fewer participants with an anxiety disorder had received a prior diagnosis compared to those with a depressive disorder. In the community sample, the rates of known diagnosis were comparable, but a significant number of patients were not receiving treatment, particularly for anxiety disorders. Further efforts are needed to improve the detection and management of psychiatric co-morbidity in people with epilepsy.

EPILEPSY & BEHAVIOR (2021)

Article Clinical Neurology

Effects of perceived stigma, unemployment and depression on suicidal risk in people with epilepsy

Yuping Zhao et al.

Summary: The study found that perceived stigma is positively associated with depression severity and suicidal risk. Depression severity acted as a mediator between perceived stigma and suicidal risk. Unemployment positively moderated the indirect effect of perceived stigma on suicidal risk through depression severity.

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2021)

Review Medicine, Research & Experimental

Psychiatric comorbidities in adult patients with epilepsy (A systematic review)

Raluca Simona Gurgu et al.

Summary: The prevalence of psychiatric disorders in epilepsy patients is high, with mood/affective disorders and anxiety disorders being the most common. Longer duration of epilepsy and childhood maltreatment experiences may be predictive factors for the occurrence of psychiatric comorbidities.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2021)

Review Clinical Neurology

Psychiatric Comorbidities in People With Epilepsy

Marco Mula et al.

Summary: It is recommended to routinely screen patients with epilepsy for psychiatric disorders, which can impact prognosis, treatment, and family communication.

NEUROLOGY-CLINICAL PRACTICE (2021)

Article Clinical Neurology

Managing depression and anxiety in people with epilepsy: A survey of epilepsy health professionals by the ILAE Psychology Task Force

Milena Gandy et al.

Summary: The study highlights the lack of resources and consensus among healthcare providers in addressing depression and anxiety in epilepsy patients. Barriers in referral practices include the lack of trained mental health specialists and standardized procedures, while accessibility difficulties are a major obstacle to patients receiving psychological treatments.

EPILEPSIA OPEN (2021)

Review Psychiatry

Prevalence and correlates of major depressive disorder: a systematic review

Luis Gutierrez-Rojas et al.

BRAZILIAN JOURNAL OF PSYCHIATRY (2020)

Review Clinical Neurology

Developments in depression in epilepsy: screening, diagnosis, and treatment

Marco Mula

EXPERT REVIEW OF NEUROTHERAPEUTICS (2019)

Article Environmental Sciences

A Meta-Analysis of the Rates of Suicide Ideation, Attempts and Deaths in People with Epilepsy

Nicholas Abraham et al.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2019)

Review Behavioral Sciences

Major depressive disorder in epilepsy clinics: A meta-analysis

Minjung Kim et al.

EPILEPSY & BEHAVIOR (2018)

Article Behavioral Sciences

Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy

Baibing Chen et al.

EPILEPSY & BEHAVIOR (2017)

Review Clinical Neurology

Management of psychiatric and neurological comorbidities in epilepsy

Andres M. Kanner

NATURE REVIEWS NEUROLOGY (2016)

Review Clinical Neurology

Treatment-resistant depression: Definitions, review of the evidence, and algorithmic approach

Roger S. McIntyre et al.

JOURNAL OF AFFECTIVE DISORDERS (2014)

Review Psychiatry

Antidepressant use in pregnancy: a critical review focused on risks and controversies

N. Byatt et al.

ACTA PSYCHIATRICA SCANDINAVICA (2013)

Review Public, Environmental & Occupational Health

The Epidemiology of Depression Across Cultures

Ronald C. Kessler et al.

ANNUAL REVIEW OF PUBLIC HEALTH, VOL 34 (2013)

Review Public, Environmental & Occupational Health

Negative effects of Antiepileptic drugs on mood in patients with epilepsy

Marco Mula et al.

DRUG SAFETY (2007)

Article Clinical Neurology

Rapid detection of major depression in epilepsy: a multicentre study

FG Gilliam et al.

LANCET NEUROLOGY (2006)